ABILITA BIO NEWS
February 21, 2023
Abilita Bio secures $7.5 million in equity financing from Two Bear Capital
Funding will Propel Abilita Bio’s Preclinical Therapeutic Programs and Accelerate the Company’s Overall Growth.Full Press Release
Press Release direct link
March 23, 2022
Abilita Bio selected as one of San Diego’s ‘Cool Companies’ 2022
Abilita Bio will also participate as a ‘Cool Company’ to the first ‘San Diego Innovation Day’ event, organized by CONNECT on April 28 at Petko Park, San Diego.
Link to the event
Link to the ‘Cool Company’ site
February 23, 2022
Abilita Bio Appoints Dan Bradbury to its Newly Formed Board of Directors
Abilita Bio, Inc., today announced the appointment of Daniel M. Bradbury to its Board of Directors. Mr. Bradbury is a seasoned biotech executive and business strategist with a formidable track record of building successful biotech companies. His guidance will be key to growing the leadership team, crafting our approach, and building a solid clinical development plan.